Evidence map›Paper›PMID 32541521›Full record

ArticleMedicine2020

Effects of bushen qianggu method for primary osteoporosis: A protocol for systematic review and meta-analysis.

Guocai Chen, Yingxin Guan, Xiangling Ye, Guoqian Chen, Jianping Du, Wengang Liu, Chuanxi Zhao, Nan Yao, Xuemeng Xu

Open access · goldAbstract read
In one paragraph

Article in Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Guocai ChenThe Fifth Clinical Medical School, Guangzhou University of Chinese Medicine.
Yingxin GuanThe Fifth Clinical Medical School, Guangzhou University of Chinese Medicine.
Xiangling YeThe Fifth Clinical Medical School, Guangzhou University of Chinese Medicine.
Guoqian ChenThe Fifth Clinical Medical School, Guangzhou University of Chinese Medicine.
Jianping DuThe Fifth Clinical Medical School, Guangzhou University of Chinese Medicine.
Wengang LiuThe Fifth Clinical Medical School, Guangzhou University of Chinese Medicine.
Chuanxi ZhaoThe Fifth Clinical Medical School, Guangzhou University of Chinese Medicine.
Nan YaoGuangdong Second Traditional Chinese Medicine Hospital.
Xuemeng XuThe Fifth Clinical Medical School, Guangzhou University of Chinese Medicine.ORCID 0000-0002-6093-7183
Guangzhou University of Chinese Medicine · CNAdvanced Materials Enterprises (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrimary osteoporosis (POP) is one of the most common orthopedic diseases with a high risk of fracture. Effective treatment of POP is of great significance to reduce the rate of disability and improve the quality of life. Bushen qianggu (BSQG) is a classical method of TCM in treating POP. However, there is no systematic review related to BSQG for POP. The purpose of this study is to provide a comprehensive and reliable evaluation of the clinical evidence of BSQG in the treatment of POP. METHODS AND ANALYSIS: Relevant randomized controlled trial literature evaluating the effect of BSQG on patients with POP will be obtained by searching the PubMed, Embase, MEDLINE, Cochrane Library Central Register of Controlled Trials, China national knowledge infrastructure database, Wan fang database, Chongqing VIP information, and SinoMed from their inception to May 2020. Two researchers will select and evaluate qualified studies independently. The bone mineral density value and the incidence of fractures will be accepted as the primary outcomes. The meta-analyses will be performed by using the RevMan 5.3.

resultsThis study will provide a comprehensive evaluation of the efficacy and safety of BSQG method for patients with POP.

conclusionThe conclusion of our systematic review will provide evidence to judge whether BSQG is an effective intervention for patients with POP. TRIAL REGISTRATION NUMBER: 10.17605/OSF.IO/ZMX3W.

Indexed as

Meta-Analysis as TopicPhytotherapyResearch DesignSystematic Reviews as TopicDrugs, Chinese HerbalHumansOsteoporosisRandomized Controlled Trials as TopicTreatment OutcomeBushen qiangduDrugs, Chinese Herbal

Identifiers

PMID32541521
PMCPMC7302671
OpenAlexW3035269841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.